Stereotaxis (STXS) Net Cash Flow (2010 - 2026)
Stereotaxis' (STXS) quarterly Net Cash Flow came in at $1.2 million in Q1 2026, up 168.4% year-over-year from $445226.1 in Q1 2025, and down 59.01% quarter-over-quarter from $2.9 million in Q4 2025.
Analysis
Stereotaxis (STXS) Net Cash Flow (2010 - 2026) Analysis & Trends
Stereotaxis (STXS) has reported Net Cash Flow for 17 consecutive years, with $1.2 million the latest figure, recorded in Q1 2026.
- On a quarterly basis, Net Cash Flow rose 168.4% year-over-year to $1.2 million in Q1 2026; TTM through Mar 2026 was $4.0 million, a 152.42% increase from a year earlier, with the FY2025 full-year figure at $985000.0, up 112.12% from the prior year.
- Net Cash Flow was $1.2 million for Q1 2026 at Stereotaxis, down from $2.9 million in the prior quarter.
- Over five years, Net Cash Flow peaked at $17.2 million in Q2 2023 and troughed at -$22.6 million in Q4 2022.
- A 5-year average of -$1.5 million and a median of -$2.3 million in 2024 frame the typical range for Net Cash Flow.
- Across the five-year window, Net Cash Flow plunged 5677.19% in 2022 and jumped 1092.31% in 2023, its largest moves.
- Over 5 years, Net Cash Flow stood at -$22.6 million in 2022, then soared by 89.31% to -$2.4 million in 2023, then soared by 158.97% to $1.4 million in 2024, then surged by 104.85% to $2.9 million in 2025, then plunged by 59.01% to $1.2 million in 2026.
- The last three Net Cash Flow figures came in at $1.2 million (Q1 2026), $2.9 million (Q4 2025), and $3.5 million (Q3 2025), per Business Quant data.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Net Cash Flow (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 179.79 Bn | 174.18 Bn | 7.27 Bn | -1.70 Bn |
| 2 | Intuitive Surgical | 127.69 Bn | 122.47 Bn | 1.96 Bn | 746.50 Mn |
| 3 | Medtronic | 117.23 Bn | 108.41 Bn | 6.34 Bn | -169.00 Mn |
| 4 | Stryker | 103.55 Bn | 100.07 Bn | 4.50 Bn | 527.00 Mn |
| 5 | Boston Scientific | 63.24 Bn | 62.70 Bn | 3.85 Bn | -892.00 Mn |
| 6 | Edwards Lifesciences | 49.97 Bn | 45.72 Bn | 1.35 Bn | 458.40 Mn |
| 7 | Alcon | 32.83 Bn | 31.37 Bn | 1.68 Bn | -222.00 Mn |
| 8 | Dexcom | 32.30 Bn | 30.35 Bn | 830.00 Mn | -8.30 Mn |
| 9 | Steris | 20.73 Bn | 20.25 Bn | 684.20 Mn | 45.10 Mn |
| 10 | Stereotaxis | 129.55 Mn | 114.93 Mn | 3.79 Mn | 1.20 Mn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Mar 31, 2026 | 1.20 Mn |
| Dec 31, 2025 | 2.92 Mn |
| Sep 30, 2025 | 3.54 Mn |
| Jun 30, 2025 | -3.70 Mn |
| Mar 31, 2025 | -1.75 Mn |
| Dec 31, 2024 | 1.42 Mn |
| Sep 30, 2024 | -4.15 Mn |
| Jun 30, 2024 | -3.06 Mn |
| Mar 31, 2024 | -2.32 Mn |
| Dec 31, 2023 | -2.41 Mn |
| Sep 30, 2023 | -952,000.00 |
| Jun 30, 2023 | 17.17 Mn |
| Mar 31, 2023 | -3.10 Mn |
| Dec 31, 2022 | -22.58 Mn |
| Sep 30, 2022 | -2.69 Mn |
| Jun 30, 2022 | -1.73 Mn |
| Mar 31, 2022 | -3.29 Mn |
| Dec 31, 2021 | -2.40 Mn |
| Sep 30, 2021 | -1.37 Mn |
| Jun 30, 2021 | 38,000.00 |